It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This study aimed to identify the prevalence of substance use before and during COVID-19; and examined its association with depression and social factors among 437 residents from the neighborhood of Harlem in Northern Manhattan, New York City. Over a third of respondents reported using any substance before COVID-19, and initiating/increasing substance use during COVID-19. The most common substances used before COVID-19 and initiated/increased during COVID-19 were smoking (20.8% vs. 18.3%), marijuana (18.8% vs. 15.3%), and vaping (14.2% and 11.4%). The percentages of any hard drug use were 7.3% and 3.4%, respectively. After adjustment, residents with mild (Prevalence Ratio [PR] = 2.86, 95% CI 1.65, 4.92) and moderate (PR = 3.21, 95% CI 1.86, 5.56) symptoms of depression, and housing insecurity (PR = 1.47, 95% CI 1.12, 1.91) had at least a 47% greater probability of initiating and/or increasing substance use. Conversely, respondents with employment insecurity (PR = 0.71, 95% CI 0.57, 0.88) were 29% less likely to report such patterns. No association was found between substance use initiation and/or increase and food insecurity. High prevalence of substance use during COVID-19 may lead residents to turn to substance use as a coping mechanism for psychosocial stressors. Thus, it is essential to provide accessible and culturally sensitive mental health and substance use services.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 The City University of New York, Center for Innovation in Mental Health, Graduate School of Public Health & Health Policy, New York, USA (GRID:grid.212340.6) (ISNI:0000 0001 2298 5718); The City University of New York, Department of Community Health and Social Sciences, Graduate School of Public Health & Health Policy, New York, USA (GRID:grid.212340.6) (ISNI:0000 0001 2298 5718)
2 Mount Sinai Kravis Children’s Hospital, Division of Pediatric Critical Care, New York, USA (GRID:grid.416167.3) (ISNI:0000 0004 0442 1996)
3 The City University of New York, Department of Community Health and Social Sciences, Graduate School of Public Health & Health Policy, New York, USA (GRID:grid.212340.6) (ISNI:0000 0001 2298 5718)
4 Graduate School of Public Health & Health Policy, The City University of New York, Harlem Health Initiative, New York, USA (GRID:grid.212340.6) (ISNI:0000 0001 2298 5718)
5 Harlem Congregations for Community Improvement, Inc., New York, USA (GRID:grid.212340.6)
6 The City University of New York, Department of Epidemiology and Biostatistics, Graduate School of Public Health & Health Policy, New York, USA (GRID:grid.212340.6) (ISNI:0000 0001 2298 5718)